Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Action and Peak Effect of High Dose of U-500 Regular Insulin In Severly Insulin Resistant Subjects With Type 2 Diabetes Mellitus

NCT02148250 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02148250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02148250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Action and Peak Effect of High Dose of U-500 Regular Insulin In Severly Insulin Resistant Subjects With Type 2 Diabetes Mellitus
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
December 31, 2017
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high insulin requirements, insulin resistance, type 2 diabetes